We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01092182
Brief Title: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

First Submitted : March 23, 2010
First Submitted that Met QC Criteria : March 23, 2010
First Posted : March 24, 2010 (Estimate)

Results First Submitted : September 29, 2021
Results First Submitted that Met QC Criteria : September 29, 2021
Results First Posted : October 19, 2021

Last Update Submitted that Met QC Criteria : November 7, 2022
Last Update Posted : November 9, 2022